Lupus nephritis

Clinical course as related to morphologic forms and their transitions
      This paper is only available as a PDF. To read, Please Download here.


      An intensive study of the course of lupus nephritis has been undertaken in 88 patients in whom strict morphologic criteria were utilized in classification. All were treated with steroid, and 17 received cytotoxic drugs in addition. Focal proliferative lupus nephritis generally follows a benign course except in the occasional instances when transition to the diffuse proliferative or membranous forms occurs. Membranous lupus nephritis, when characterized by persistent nephrotic syndrome, leads slowly to renal failure, but this progression is aborted in the one-third in whom remission of the nephrotic syndrome can be achieved. A fatal outcome occurs within five years in the majority of those with diffuse proliferative lupus nephritis and the nephrotic syndrome, often in association with necrotizing renal vasculitis, severe hypertension and accelerated renal failure. A small number with the diffuse proliferative form have a remission and then show only mesangial abnormalities, usually, however, with the appearance of glomerular sclerosis. Progressive glomerular sclerosis is observed in some patients and may be a sequel of the remission of the diffuse or focal proliferative lesions, or it may represent still another form of lupus nephritis. Mesangial immune deposits with or without proliferation, at times in the absence of clinical renal disease, are observed early in the course of systemic lupus erythematosus (SLE) and may proceed to the diffuse proliferative or membranous forms.
      The present observations serve to emphasize the importance of strict morphologic classification in the comparison of different treatment regimens for lupus nephritis. In view of the grave prognosis of established diffuse proliferative lupus nephritis, which probably evolves from a mesangial involvement common to all patients with SLE from its onset, early therapy may be the key to the management of lupus nephritis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Baldwin DS
        • Lowenstein J
        • Rothfield NF
        • et al.
        The clinical course of the proliferative and membranous forms of lupus nephritis.
        Ann Intern Med. 1970; 73: 929
        • McCluskey RT
        • Vassalli P
        • Gallo G
        • et al.
        An immunofluorescent study of pathogenic mechanisms in glomerular diseases.
        N Engl J Med. 1966; 274: 695
        • Cutler SJ
        • Ederer F
        Maxium utilization of the life table method in analyzing survival.
        J Chronic Dis. 1958; 8: 699
        • Dubois EL
        • Wierzchowiecki M
        • Cox MB
        • et al.
        Duration and death in systemic lupus erythematosus. An analysis of 249 cases.
        JAMA. 1974; 227: 1399
        • Gluck MC
        • Gallo G
        • Lowenstein J
        • et al.
        Membranous glomerulonephritis. Evolution of clinical and pathologic features.
        Ann Intern Med. 1973; 78: 1
        • Rothfield NF
        • McCluskey RT
        • Baldwin DS
        Renal disease in systemic lupus erythematosus.
        N Engl J Med. 1963; 269: 537
        • Baldwin DS
        • McCluskey RT
        Renal involvement in systemic lupus erythematosus, periarteritis nodosa, scleroderma, and cryoglobulinemia.
        (chap 12)in: Becker EL Structural Basis of Renal Disease. Hoeber Medical Division, Harper & Row, New York1968
      1. Koffler D, Schur PH, Kunkel HG: Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126: 607, 1067.

        • Cheatum DE
        • Hurd ER
        • Strunk SW
        • et al.
        Renal histology and clinical course of systemic lupus erythematosus' A prospective study.
        Arthritis Rheum. 1973; 16: 670
        • Grishman E
        • Porush JG
        • Lee SL
        • et al.
        Renal biopsies in lupus nephritis. Correlation of electron microscopic findings with clinical course.
        Nephron. 1973; 10: 25
        • Ginzler EM
        • Nicastri AD
        • Chun-Kuo C
        • et al.
        Progression of mesangial and focal to diffuse lupus nephritis.
        N Engl J Med. 1974; 291: 693
        • Zweiman B
        • Kornblum J
        • Cornog J
        • et al.
        The prognosis of lupus nephritis. Role of clinical-pathologic correlations.
        Ann Intern Med. 1968; 69: 441
        • Pollak VE
        • Pirani CL
        • Schwartz FD
        The natural history of the renal manifestations of systemic lupus erythematosus.
        J Lab Clin Med. 1964; 63: 537
        • Shelp WD
        • Bloodworth Jr, JMB
        • Rieselbach RE
        Effect of azathioprine on renal histology and function in lupus nephritis.
        Arch Intern Med. 1971; 128: 566
        • Donadio Jr, JV
        • Wagoner RD
        • McDuffie FC
        Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
        Ann Intern Med. 1972; 77: 829
        • Nanra RS
        • Kincaid-Smith P
        Lupus nephritis. Clinical course in relation to treatment, sec XII. Glomerulonephritis.
        in: Kincaid-Smith P Mathew TH Becker EL Morphology, Natural History and Treatment. John Wiley & Sons, New York1973
        • Striker GE
        • Keely MR
        • Quadracci LJ
        • et al.
        The course of lupus nephritis. A clinical-pathological correlation of 50 patients, sec XII. Glomerulonephritis.
        in: Kincaid-Smith P Mathew TH Becker EL Morphology, Natural History and Treatment. John Wiley & Sons, New York1973
        • Cameron JS
        • Jones MB
        Lupus nephritis. Long-term follow up, sec XII. Glomerulonephritis.
        in: Kincaid-Smith P Mathew TH Becker EL Morphology, Natural History and Treatment. John Wiley & Sons, New York1973
        • Mery JP
        • Morel-Maroger L
        • Boelaert J
        • et al.
        Evolution anatomoclinique des glomerulites diffuses et focales au cours du lupus erythemateux dissemine.
        J Urol Nephrol. 1973; 4–5: 321
        • Pollak VE
        • Pirani CL
        • Kark RM
        Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis.
        J Lab Clin Med. 1961; 57: 495
        • Hayslett JP
        • Kashgarian M
        • Cook CD
        • et al.
        The effect of azathioprine on lupus glomerulonephritis.
        Medicine (Baltimore). 1972; 51: 393
        • Morel-Maroger L
        • Mery J Ph.
        • Richet G
        Lupus nephritis: immunofluorescence study of 54 cases, sec XII. Glomerulonephritis.
        in: Kincaid-Smith P Mathew TH Becker EL Morphology, Natural History and Treatment. John Wiley & Sons, New York1973
        • Zimmerman SW
        • Jenkins PG
        • Shelp WD
        • et al.
        Progression from minimal or focal to diffuse proliferative lupus nephritis.
        Lab Invest. 1975; 32: 665
        • Comerford FR
        • Cohen AS
        The nephropathy of systemic lupus erythematosus. An assessment by clinical, light and electron microscopic criteria.
        Medicine (Baltimore). 1967; 46: 425
        • Pollak VE
        • Pirani CL
        • Dujovne I
        • et al.
        The clinical course of lupus nephritis. Relationship to the renal histologic findings, sec XII. Glomerulonephritis.
        in: Kincaid-Smith P Mathew TH Becker EL Morphology, Natural History, and Treatment. John Wiley & Sons, New York1973
        • Chasis H
        • Goldring W
        • Baldwin DS
        Effect of febrile plasma: typhoid vaccine and nitrogen mustard on renal manifestations of glomerulonephritis.
        in: Proc Soc Exp Biol Med. 71. 1949: 565
        • Baldwin DS
        • McLean PG
        • Chasis H
        • et al.
        Effect of nitrogen mustard on the clinical course of glomerulonephritis.
        Arch Intern Med. 1953; 92: 162
        • Dubois EL
        Nitrogen mustard in treatment of SLE.
        Arch Intern Med. 1954; 93: 667
        • Bardana Jr, EJ
        • Porter GA
        • Pirofsky B
        • et al.
        Azathioprine in steroid-insensitive nephropathy.
        Am J Med. 1970; 49: 789
        • Drinkard JP
        • Stanley TM
        • Dornfeld L
        • et al.
        Azathioprine and prednisone in the treatment of adults with lupus nephritis.
        Medicine (Baltimore). 1970; 49: 411
        • Cameron JS
        • Boulton-Jones M
        • Robinson R
        • et al.
        Treatment of lupus nephritis with cyclophosphamide.
        Lancet. 1970; 2: 846
        • Steinberg AD
        • Kaltreider B
        • Staples PJ
        • et al.
        Cyclophosphamide in lupus nephritis. A controlled trial.
        Ann Intern Med. 1971; 75: 165
        • Sztejmbok M
        • Stewart A
        • Diamond H
        • et al.
        Azathioprine in the treatment of systemic lupus erythematosus. A controlled study.
        Arthritis Rheum. 1971; 14: 639
        • Cade R
        • Spooner G
        • Schiein E
        • et al.
        Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis.
        Nephron. 1973; 10: 37
        • Dillard MG
        • Dujovne I
        • Pollak VE
        • et al.
        The effect of treatment with prednisone and nitrogen mustard on the renal lesions and life span of patients with lupus glomerulonephritis.
        Nephron. 1973; 10: 273
        • Steinberg AD
        • Decker JL
        A double-blind controlled trial comparing cyclophosphamide azathioprine and placebo in the treatment of lupus glomerulonephritis.
        Arthritis Rheum. 1974; 17: 923
        • Lange K
        • Ores R
        • Strauss W
        • et al.
        Steroid therapy of systemic lupus erythematosus based on immunologic considerations.
        Arthritis Rheum. 1965; 8: 244
        • Decker JL
        • Klippel JH
        • Plotz PH
        • et al.
        Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
        Ann Intern Med. 1975; 83: 606
        • Hahn BH
        • Kantor OS
        • Osterland CK
        Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
        Ann Intern Med. 1975; 85: 597